Zoth Lota S.
Insider CIK 1278219 · INO Director · (NLNK) Director · OREX Director · HPTX Director · ZYME Director · ONCE CHIEF SCIENTIFIC OFFICER, Director · ETNB Director · ZYME Director · ENGN Director · FFIN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ENGN enGene Therapeutics Inc. | A Award deriv | 2026-06-16 | 2026-06-17 | 31,000 | — | $0 | 31,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2026-05-20 | 2026-05-21 | 34,200 | — | $0 | 34,200 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2026-05-20 | 2026-05-21 | 41,800 | — | $0 | 41,800 | SEC↗ |
| FFIN FIRST FINANCIAL BANKSHARES | A Award | 2026-04-28 | 2026-05-05 | 2,142 | — | $0 | 2,142 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 56,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 45,150 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 27,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 12,500 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 20,000 | — | $0 | 0 | SEC↗ |
| ENGN enGene Holdings Inc. | A Award deriv | 2025-06-16 | 2025-06-16 | 22,500 | — | $0 | 22,500 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2025-05-21 | 2025-05-21 | 2,167 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2025-05-21 | 2025-05-21 | 2,167 | — | $0 | 8,726 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 56,400 | — | $0 | 56,400 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,328 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,345 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 5,684 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,431 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,910 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,777 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 5,324 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer | 2024-12-12 | 2024-12-13 | 2,187 | — | $0 | 0 | SEC↗ |
| ENGN enGene Holdings Inc. | A Award deriv | 2024-06-15 | 2024-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2024-06-05 | 2024-06-07 | 3,328 | — | $0 | 3,328 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2024-05-21 | 2024-05-22 | 2,917 | — | $0 | 2,917 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2024-05-21 | 2024-05-22 | 2,167 | — | $0 | 2,167 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2024-05-15 | 2024-05-16 | 2,166 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2024-05-15 | 2024-05-16 | 2,166 | — | $0 | 6,559 | SEC↗ |
| ENGN enGene Holdings Inc. | A Award deriv | 2024-03-21 | 2024-03-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 45,150 | — | $0 | 45,150 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2023-06-05 | 2023-06-05 | 5,700 | $0.56 | $3.2K | 52,716 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2023-05-16 | 2023-05-16 | 19,000 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2023-05-16 | 2023-05-16 | 19,000 | — | $0 | 58,416 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2023-05-15 | 2023-05-16 | 26,000 | — | $0 | 26,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2023-05-15 | 2023-05-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2023-05-10 | 2023-05-12 | 3,345 | — | $0 | 3,345 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2023-02-09 | 2023-02-13 | 27,400 | — | $0 | 27,400 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2022-12-21 | 2022-12-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2022-05-16 | 2022-05-17 | 28,000 | — | $0 | 28,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2022-05-16 | 2022-05-17 | 19,000 | — | $0 | 19,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2022-05-16 | 2022-05-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2022-05-16 | 2022-05-17 | 3,600 | $1.98 | $7.1K | 39,416 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2022-05-13 | 2022-05-17 | 18,000 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2022-05-13 | 2022-05-17 | 18,000 | — | $0 | 43,016 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2022-05-05 | 2022-05-09 | 3,431 | — | $0 | 3,431 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2022-01-05 | 2022-01-05 | 961 | $5.01 | $4.8K | 25,016 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2022-01-03 | 2022-01-05 | 4,090 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2022-01-03 | 2022-01-05 | 4,090 | — | $0 | 25,977 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2021-05-20 | 2021-05-24 | 2,910 | — | $0 | 2,910 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2021-05-20 | 2021-05-24 | 367 | — | $0 | 2,187 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2021-05-17 | 2021-05-17 | 2,045 | $6.62 | $13.5K | 21,887 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2021-05-14 | 2021-05-17 | 8,700 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2021-05-14 | 2021-05-17 | 8,700 | — | $0 | 23,932 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2021-05-13 | 2021-05-17 | 18,000 | — | $0 | 18,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2021-05-13 | 2021-05-17 | 27,000 | — | $0 | 27,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2021-05-06 | 2021-05-07 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2021-04-15 | 2021-04-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2021-01-05 | 2021-01-05 | 961 | $9.48 | $9.1K | 15,232 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2021-01-03 | 2021-01-05 | 4,090 | — | $0 | 4,090 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2021-01-03 | 2021-01-05 | 4,090 | — | $0 | 16,193 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2020-06-12 | 2020-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2020-05-14 | 2020-05-15 | 13,300 | — | $0 | 13,300 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2020-05-14 | 2020-05-15 | 8,700 | — | $0 | 8,700 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2020-05-08 | 2020-05-08 | 8,013 | — | $0 | 0 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2020-05-08 | 2020-05-12 | 9,000 | — | $0 | 9,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2020-05-08 | 2020-05-08 | 8,013 | — | $0 | 12,103 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2020-04-03 | 2020-04-07 | 5,684 | — | $0 | 5,684 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2020-04-03 | 2020-04-07 | 709 | — | $0 | 1,820 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2020-01-03 | 2020-01-06 | 4,090 | — | $0 | 8,180 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2020-01-03 | 2020-01-06 | 4,090 | — | $0 | 4,090 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award | 2020-01-02 | 2020-01-06 | 2,100 | — | $0 | 10,006 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 6,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 12,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 4,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 4,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | U Tender | 2019-12-17 | 2019-12-17 | 3,000 | $114.50 | $343.5K | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 15,659 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 11,904 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 3,968 | — | $0 | 3,968 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 10,713 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 3,571 | — | $0 | 3,571 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 13,889 | — | $0 | 13,889 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 27,777 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 4,437 | — | $0 | 4,437 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 13,309 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 2,392 | — | $0 | 2,392 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 4,783 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 8,887 | — | $0 | 8,887 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 17,773 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 1,588 | — | $0 | 1,588 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 6,349 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 5,220 | — | $0 | 5,220 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 12,000 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2019-05-30 | 2019-06-03 | 1,500 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2019-05-30 | 2019-06-03 | 1,500 | — | $0 | 3,000 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-05-10 | 2019-05-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2019-05-08 | 2019-05-09 | 12,500 | — | $0 | 12,500 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2019-05-08 | 2019-05-09 | 8,013 | — | $0 | 8,013 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2019-05-06 | 2019-05-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2019-01-03 | 2019-01-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2019-01-03 | 2019-01-04 | 12,270 | — | $0 | 12,270 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2018-05-31 | 2018-05-31 | 1,500 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2018-05-31 | 2018-05-31 | 1,500 | — | $0 | 1,500 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2018-05-30 | 2018-05-31 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2018-05-30 | 2018-05-31 | 1,500 | — | $0 | 1,500 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2018-05-23 | 2018-05-25 | 27,777 | — | $0 | 27,777 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2017-07-14 | 2017-07-18 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2017-05-31 | 2017-06-02 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2017-05-31 | 2017-06-02 | 1,500 | — | $0 | 1,500 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2017-05-12 | 2017-05-16 | 13,309 | — | $0 | 13,309 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2016-08-09 | 2016-08-11 | 4,783 | — | $0 | 4,783 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2016-08-09 | 2016-08-11 | 17,773 | — | $0 | 17,773 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2016-06-01 | 2016-06-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2016-01-06 | 2016-01-08 | 12,000 | — | $0 | 12,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2015-06-09 | 2015-06-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 11,855 | $46.00 | $545.3K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 4,105 | $46.00 | $188.8K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 14,700 | $46.00 | $676.2K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 4,869 | $46.00 | $224.0K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 55 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer | 2015-05-07 | 2015-05-08 | 2,617 | $46.00 | $120.4K | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2015-04-30 | 2015-07-17 | 6,349 | — | $0 | 6,349 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2015-04-30 | 2015-05-04 | 3,643 | — | $0 | 3,643 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award | 2015-04-30 | 2015-05-04 | 1,962 | — | $0 | 7,906 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2014-06-27 | 2014-06-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2014-05-27 | 2014-05-29 | 4,869 | — | $0 | 4,869 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award | 2014-05-27 | 2014-05-29 | 2,617 | — | $0 | 2,617 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2014-05-01 | 2015-07-17 | 15,659 | — | $0 | 15,659 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2014-05-01 | 2014-05-05 | 8,831 | — | $0 | 8,831 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award | 2014-05-01 | 2014-05-05 | 2,944 | — | $0 | 5,944 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award | 2014-01-02 | 2014-01-06 | 3,000 | — | $0 | 3,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2013-06-05 | 2013-06-07 | 35,000 | — | $0 | 35,000 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2013-05-09 | 2013-05-10 | 12,000 | — | $0 | 12,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2013-04-15 | 2013-05-01 | 14,700 | — | $0 | 14,700 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2012-06-07 | 2012-06-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2012-04-26 | 2012-04-30 | 35,000 | — | $0 | 35,000 | SEC↗ |